Sensorion, a clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, has raised €50.5m (US$54.5m) through a reserved offering of 88,594,737 new…
France: Sensorion extends cash runaway with €50.5m reserved offering
…
…






